The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... Nature 483 (7391), 603-607, 2012 | 8043 | 2012 |
Comprehensive genomic characterization defines human glioblastoma genes and core pathways Cancer Genome Atlas Research Network Tissue source sites: Duke University ... Nature 455 (7216), 1061-1068, 2008 | 7514 | 2008 |
Mutational heterogeneity in cancer and the search for new cancer-associated genes MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ... Nature 499 (7457), 214-218, 2013 | 5942 | 2013 |
A landscape of driver mutations in melanoma E Hodis, IR Watson, GV Kryukov, ST Arold, M Imielinski, JP Theurillat, ... Cell 150 (2), 251-263, 2012 | 3011 | 2012 |
The mutational landscape of head and neck squamous cell carcinoma N Stransky, AM Egloff, AD Tward, AD Kostic, K Cibulskis, A Sivachenko, ... science 333 (6046), 1157-1160, 2011 | 2862 | 2011 |
Next-generation characterization of the cancer cell line encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503-508, 2019 | 2630 | 2019 |
Comprehensive and integrative genomic characterization of hepatocellular carcinoma A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ... Cell 169 (7), 1327-1341. e23, 2017 | 2003 | 2017 |
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ... Nature genetics 44 (6), 685-689, 2012 | 1757 | 2012 |
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation CM Johannessen, JS Boehm, SY Kim, SR Thomas, L Wardwell, ... Nature 468 (7326), 968-972, 2010 | 1741 | 2010 |
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer R Possemato, KM Marks, YD Shaul, ME Pacold, D Kim, K Birsoy, ... Nature 476 (7360), 346-350, 2011 | 1700 | 2011 |
Sequence analysis of mutations and translocations across breast cancer subtypes S Banerji, K Cibulskis, C Rangel-Escareno, KK Brown, SL Carter, ... Nature 486 (7403), 405-409, 2012 | 1420 | 2012 |
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing JG Lohr, P Stojanov, MS Lawrence, D Auclair, B Chapuy, C Sougnez, ... Proceedings of the National Academy of Sciences 109 (10), 3879-3884, 2012 | 1153 | 2012 |
The landscape of kinase fusions in cancer N Stransky, E Cerami, S Schalm, JL Kim, C Lengauer Nature communications 5 (1), 4846, 2014 | 1031 | 2014 |
Melanoma genome sequencing reveals frequent PREX2 mutations MF Berger, E Hodis, TP Heffernan, YL Deribe, MS Lawrence, ... Nature 485 (7399), 502-506, 2012 | 892 | 2012 |
An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules A Basu, NE Bodycombe, JH Cheah, EV Price, K Liu, GI Schaefer, ... Cell 154 (5), 1151-1161, 2013 | 787 | 2013 |
Analysis of array CGH data: from signal ratio to gain and loss of DNA regions P Hupe, N Stransky, JP Thiery, F Radvanyi, E Barillot Bioinformatics 20 (18), 3413-3422, 2004 | 686 | 2004 |
Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell reports 18 (11), 2780-2794, 2017 | 673 | 2017 |
Targeting cancer with kinase inhibitors S Gross, R Rahal, N Stransky, C Lengauer, KP Hoeflich The Journal of clinical investigation 125 (5), 1780-1789, 2015 | 536 | 2015 |
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer HW Cheung, GS Cowley, BA Weir, JS Boehm, S Rusin, JA Scott, A East, ... Proceedings of the National Academy of Sciences 108 (30), 12372-12377, 2011 | 515 | 2011 |
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods BJ Haas, A Dobin, B Li, N Stransky, N Pochet, A Regev Genome biology 20, 1-16, 2019 | 482 | 2019 |